Robertson Rebecca B reported option exercise involving 8,759 shares of TANDEM DIABETES CARE INC at $0.00 for $0 on May 21, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Director
DIR
Filed May 22, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
8,759Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
22,542Direct
Trade date
May 21, 2026Option exercise
Filed
May 22, 2026, 4:06 PM ET1-day reporting delay
Accession
0001438133-26-000074Code M · Transaction 383889
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 20, 2026Grant10,220$0.00$0Trade 383890
May 21, 2026Option exercise8,759$0.00$0Trade 383891
3 transaction rows in this filing. Joint filers share the same rows.

TNDM price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
TNDM · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +34%1w ago −5.5%1d ago +0.5%
Returns since7d +15%30d +2.2%90d +51%180d1y

Footnotes in full

F1: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F2: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan. F3: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan.